Mayo Clinic, Duke Conducting Study Comparing FUS With Uterine Artery Embolization

September 27, 2011
36 Views

Patient enrollment is underway for the first US-based study comparing MR-guided focused ultrasound and uterine artery embolization (UAE) for the treatment of uterine fibroids. The study, called The Fibroid Interventions: Reducing Symptoms Today and Tomorrow (FIRSTT) trial, is now open at the Mayo Clinic in Rochester, MN and at Duke University in Durham, NC. Study participants will be randomly assigned for treatment with either FUS or UAE.

Patient enrollment is underway for the first US-based study comparing MR-guided focused ultrasound and uterine artery embolization (UAE) for the treatment of uterine fibroids. The study, called The Fibroid Interventions: Reducing Symptoms Today and Tomorrow (FIRSTT) trial, is now open at the Mayo Clinic in Rochester, MN and at Duke University in Durham, NC. Study participants will be randomly assigned for treatment with either FUS or UAE.

Expected to provide important insights regarding the benefits and potential drawbacks of newer non-surgical treatment approaches for uterine fibroids, the study will follow patients for three years. Its goal is to assess how effective treatments are in symptom relief, side effects, impact on women’s quality of life, need for additional treatment, potential for future fertility and even the costs associated with each approach.

“Many women suffering from fibroids go to their local doctor and are offered hysterectomy to treat their fibroids, but are given no long-lasting alternatives to surgery,” says Elizabeth A. Stewart, MD, Professor of Obstetrics and Gynecology at the Mayo Clinic. “Both UAE and FUS are excellent less invasive options for women, but we have very little scientific evidence comparing these two approaches. The major goal of this important study is to generate information that will guide physicians and patients on the options that are right for them.”

The success of the FIRSTT trial depends on women participating in the research. The study seeks to enroll 220 women who can be treated at The Mayo Clinic in Rochester, Minnesota or Duke University in Durham, North Carolina. Complete information about the study and its eligibility requirements can be found here.

A Facebook group for women interested in the study has been established. Follow this link if you are interested.

You may be interested

Where Is The Balance? Pushing Back Against Consumer Health Tech
eHealth
1 views
eHealth
1 views

Where Is The Balance? Pushing Back Against Consumer Health Tech

Larry Alton - August 18, 2017

When Republican Congressman Jason Chaffetz glibly remarked that Americans struggling to afford insurance should choose between that and their smartphones,…

What to Look for in Patient Solutions Software
eHealth
365 views
eHealth
365 views

What to Look for in Patient Solutions Software

Robert Cordray - August 17, 2017

The medical sector is one area where technology has had a significant impact, largely by providing tools that simplify many…

Can Natural Remedies Like RediCalm Decrease Stress and Anxiety?
Wellness
2 views
Wellness
2 views

Can Natural Remedies Like RediCalm Decrease Stress and Anxiety?

Ryan Kh - August 16, 2017

According to research from the National Institute of Mental Health, anxiety disorders are the most common mental illness in the…